Incremental cost-effectiveness of incorporating oestriol evaluation in down syndrome screening programmes

As screening for Down syndrome becomes increasingly sophisticated, it is important to evaluate the newer technologies in terms of their cost-effectiveness. One recent addition to Down syndrome screening programmes is maternal serum unconjugated oestriol (uE₃), especially when used in conjunction with maternal serum α-fetoprotein and human chorionic gonadotropin. Using assumptions used in a California proposal to justify an expanded screening programme for Down syndrome, we calculated both the average and the incremental cost-effectiveness of adding uE₃. Using the base case assumptions, including an $8 fee for the uE₃, the incremental cost-effectiveness of adding uE₃ to the proposed California programme is $119 100 per case detected, a value that compares favourably with other Down syndrome screening programmes. The sensitivity analysis supports this conclusion over a wide range of assumptions. However, because of the uncertainty with some key data, it is still too early to fully support the inclusion of uE₃ in Down syndrome screening programmes.     

Transvaginal chorionic villus sampling

Chorionic villus sampling (CVS) with either transcervical catheters or transabdominal needles is a widely-accepted method for prenatal diagnosis. However, there exists a small subset of patients in whom sampling is difficult or impossible with either route because of individual anatomic variations. A new method of chorionic villus biopsy has been developed to circumvent these problems, utilizing transvaginal chorionic needle aspiration guided by an intravaginal ultrasound probe. This technique was performed successfully in 15 patients in whom villi could not be obtained by either of the conventional methods. This method now makes CVS possible in essentially all women regardless of their uterine anatomy or placental placement; it may also prove useful for very early chorionic sampling.     

Prenatal diagnosis of cystinosis utilizing chorionic villus sampling

The prenatal diagnosis of cystinosis is currently based on the increased amount of free-cystine present in amniotic fluid cells. Amniocyte cultures must be grown for at least 2 weeks to obtain sufficient cells for such measurements. Thus, the diagnosis cannot be made until close to 20 weeks gestational age by this method. We report a case in which chorionic villi were used for direct cystine measurement resulting in the in utero diagnosis of cystinosis at 9 weeks gestational age. The diagnosis was confirmed by the study of cultured chorionic villus cells, and of the 10-week abortus.     

The importance of chorionic villus sampling after first trimester diagnosis of cystic hygroma

The prenatal diagnosis of The Turner Syndrome is described at a menstrual age of 12 weeks. Detection of cystic hygroma was followed by vaginal chorionic villous sampling (CVS) which revealed a 45,X karyotype. Early documentation of fetal karyotype in the presence of a cystic hygroma is essential for accurate diagnosis and genetic counselling.     

林丹(γ-六六六)在土壤中的吸附性与其在土壤和小麦中残留量的关系

本文利用~(14)C—林丹研究了γ-六六六在不同土壤中的吸附性及其在土壤和小麦中残留量的关系。试验表明,γ-六六六在土壤中的吸附率与土壤中的有机质含量、可萃取铝含量和酸性等均有密切关系。同时,环境温度对吸附率也有一定影响。通过~(14)C—林丹在不同土壤和小麦植株中残留量的测定,证明土壤中γ-六六六的吸附率、小麦对土壤中r-六六六的吸收率以及γ-六六六在土壤和小麦中的残留量相互之间均有明显的相关性。为此,本研究不仅摸清了某些影响土壤吸附γ-六六六和小麦吸收γ-六六六的理化因子,同时,对用土壤某些理化性质的测定值来预测栽培试验时土壤和小麦中六六六的残留水平提供了一个途径。     

消油剂乳化率检验中标准曲线的选择

本文经过比实验，详细研究了添加双象１号消油剂对原油标线的影响，并对乳化率检验中的两种标准曲线进行了统计检验。结果表明：不添加消油剂制作的原油标线可使乳化率结果降低１￣３％左右，甚至个别消油剂的乳化率结果可相差２０％左右，两条标线的统计差异非常显著。所以制作标准曲线时必须按比例添加消测剂才能确保执法数据的可靠性。     

总有机碳测定仪的新用途──测气体中CO_2的研究

用ＴＯＣ总有机碳测定仪来鉴定污水和生活用水处理效果及污染指标是它的一项实际应用，而本义介绍的用来测定ＣＯ２则是一项开创性的工作。作者在对进口的ＴＯＣ仪使用的基础上研究了测定气体中总碳、总有机碳尤其是ＣＯ２问题，取得了较好的结果并应用到实际测定中。